Rat CD8a Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Rat CD8a antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityRat CD8a
Clone[OX-8]
Host SpeciesMouse
Reactive Speciesrat
IsotypeIgG1
Formatbiotin conjugate
Size0.1 mg, 0.5 mg
ConcentrationAntibody concentration: 0.1 mg/ml
ApplicationsImmunohistochemistry (IHC), Western Blot (WB), Flow Cytometry (FC/FACS)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: CD8a (Rat CD8a). anti-rat CD8a monoclonal antibody recognizes a determinant on the majority of thymocytes (90-95%), a subset of peripheral T cells, the majority of NK cells, and the granular intraepithelial leukocytes in the small intestine. (1,2,3,4.) The antigen recognized is a complex of surface glycoproteins of Mr 34,000, 39,000 and 76,000 Da and is the rat homologue of the human CD8 and the mouse Ly-2,3 antigen. (5,8) MBS520223 labels all peripheral T cells that are unlabelled by the (W3/25) monoclonal antibody. It labels a T-cell subset which mediates the suppression of antibody formation (1) and the cytotoxic cell precursor. (2) MBS520223 can be used together to fractionate T cells by sorting in FACS or by rosette deplet
ImmunogenImmunogen: High molecular weight rat thymocyte glycoproteins. Donor: BALB/c spleen. Fusion Partner: P3-NSI-1-Ag4 (NSI/1)
Other Names[CD8a Biotin (Clone OX-8) (mouse IgG1); Biotin Rat CD8a], [CD8A; CD8A; CD8; MAL; p32; Leu2; MAL]
Gene, Accession #[CD8a], Gene ID: 925, NCBI: AAH25715.1, UniProt: P01732
Catalog #MBS520223
Price$250, $420
Order / More InfoRat CD8a Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.